The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma

Anaesthesia

Volumn 60, Issue 6, 2005, Pages 613-616

  Udy, Andrew ^a   Vaghela, M ^a   Lawton, G ^a   Sigston, P ^a  

^a KENT AND SUSSEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG USE; EMERGENCY TREATMENT; ERYTHROCYTE TRANSFUSION; FRACTURE EXTERNAL FIXATION; HEMATOMA; HEMOSTASIS; HOSPITAL DISCHARGE; HUMAN; INTERMITTENT POSITIVE PRESSURE VENTILATION; LAPAROTOMY; MALE; PELVIS FRACTURE; PELVIS INJURY; POSTOPERATIVE HEMORRHAGE; RESUSCITATION; SINGLE DRUG DOSE; TRAFFIC ACCIDENT; TREATMENT OUTCOME; X RAY;

ACCIDENTS, TRAFFIC; ADOLESCENT; ADULT; FACTOR VII; HEMORRHAGE; HEMOSTATICS; HUMANS; MALE; PELVIC BONES; PELVIS; PLATELET TRANSFUSION; RECOMBINANT PROTEINS; WOUNDS, NONPENETRATING;

EID: 19944389258     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2005.04154.x     Document Type: Article

References (18)

1. Mann KG. Biochemistry and physiology of blood coagulation. Thrombosis and Haemostasis 1999; 82: 165-74.
2. Hedner U. Dosing with recombinant factor VIIa based on current evidence. Seminars in Hematology 2004; 41 (1, Suppl. 1): 35-9.
3. Hoffman M, Monroe DM III, Roberts HR. Activated factor VII activates factors IX and X on the surface of activated platelets: Thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagulation & Fibrinolysis. An International Journal in Haemostasis and Thrombosis 1998; 9 (Suppl. 1): S61-5.
4. Hedner U. Recombinant factor VIIa (Novoseven) as a hemostatic agent. Seminars in Hematology 2001; 38 (4, Suppl. 12): 43-7.
5. Murkin JM. A novel haemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice. Canadian Journal of Anaesthesia 2002; 49: S21-6.
6. Price G, Kaplan J, Skowronski G. Use of recombinant factor VIIa to treat life-threatening non-surgical bleeding in a postpartum patient. British Journal of Anaesthesia 2004; 93: 298-300.
7. Segal S, Shemesh IY, Blumenthal R, et al. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa). Archives of Gynecology and Obstetrics 2003; 268: 266-7.
8. Bouwmeester FW, Jonkhoff AR, Verheijen RH, van Geijn HP. Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII. Obstetrics and Gynecology 2003; 101: 1174-6.
9. Wahlgren CM, Swedenborg J. The use of recombinant activated VII to control bleeding during repair of a suprarenal abdominal aortic aneurysm. European Journal of Vascular and Endovascular Surgery 2003; 26: 221-2.
10. Kaw LL Jr, Coimbra R, Potenza BM, Garfin SR, Hoyt DB. The use of recombinant factor VIIa for severe intractable bleeding during spine surgery. Spine 2004; 29: 1384-7.
11. Romero-Castro R, Jimenez-Saenz M, Pellicer-Bautista F, et al. Recombinant-activated factor VII as hemostatic therapy in eight cases of severe hemorrhage from esophageal varices. Clinical Gastroenterology and Hepatology 2004; 2: 78-84.
12. Friederich PW, Henny CP, Messelink EJ, et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double blind placebo controlled trial. Lancet 2003; 361: 201-5.
13. Danilos J, Goral A, Paluszkiewicz P, Przesmycki K, Kotarski J. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery. Obstetrics and Gynecology 2003; 101: 1172-3.
14. Martinowitz U, Kenet G, Segal E, et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. Journal of Trauma, Injury, Infection and Critical Care 2001; 51: 431-9.
15. Boffard KD, Warren B, Iau P. Decreased transfusion utilization and improved outcome associated with the use of recombinant factor VIIA as an adjunct in trauma. Abstract of a paper to be presented at the Sixty-third Annual Meeting of the American Association for Surgery of Trauma. Journal of Trauma, Injury, Infection, and Critical Care 2004; 57: 451.
16. Roberts HR, Monroe DM III, Hoffman M. Safety profile of recombinant factor VIIa. Seminars in Hematology 2004; 41 (1, Suppl. 1): 101-8.
17. Peerlinck K, Vermylen J. Acute myocardial infarction following administration of recombinant activated factor VII (NovoSeven) in a patient with haemophiha A and inhibitor. Thrombosis and Haemostasis 1999; 82: 1775-6.
18. Gielen-Wijffels S, van Mook W, van der Geest S, Ramsay G. Successful treatment of severe bleeding with recombinant factor VIIa after kidney transplantation. Intensive Care Medicine 2004; 30: 1232-4.